1) Stashak TS, Theoret CL. Equine wound management. 2nd ed. Iowa: WileyBlackwell; 2008.
2) Caron JP. Management of superficial wounds. In: Auer JA, editor. Equine Surgery.
Philadelphia: W. B. Saunders Company; 1992. p. 232.
3) Iacopetti I, Perazzi A, Ferrari V, Busetto R. Application of platelet-rich gel to
enhance wound healing in the horse: A case report. J Equine Vet Sci. 2012;32:123–
8.
4) DeRossi R, Coelho AC, Mello GS, Frazílio FO, Leal CR, Facco GG, et al. Effects of
platelet-rich plasma gel on skin healing in surgical wound in horses. Acta Cir Bras.
2009 Jul–Aug;24(4):276–81.
5) Rajabzadeh N, Fathi E, Farahzadi R. Stem cell-based regenerative medicine. Stem
Cell Investig. 2019 Jul 18;6:19.
6) Torres-Torrillas M, Rubio M, Damia E, Cuervo B, Del Romero A, Peláez P, et al.
Adipose-Derived Mesenchymal Stem Cells: A Promising Tool in the Treatment of
Musculoskeletal Diseases. Int J Mol Sci. 2019 Jun 25;20(12):3105.
7) 澤芳樹. 「再生医療の最前線」
『医療と社会』
、2018;28(1): 93–101.
96
8) Borena BM, Martens A, Broeckx SY, Meyer E, Chiers K, Duchateau L, et al.
Regenerative Skin Wound Healing in Mammals: State-of-the-Art on Growth Factor
and Stem Cell Based Treatments. Cell Physiol Biochem. 2015;36(1):1–23.
9) Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg.
2004 Apr;62(4):489–96.
10) Everts PA, Knape JT, Weibrich G, Schönberger JP, Hoffmann J, Overdevest EP, et
al. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol. 2006
Jun;38(2):174–87.
11) Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors
and cytokines in wound healing. Wound Repair Regen. 2008 Sep–Oct;16(5):585–
601.
12) Satue K, Gardon JC, Munoz A. Interpretation of platelets in the horse. J Hematol.
Res. 2017;4:19–25.
13) Reed SM, Bayly WM, Sellon DC. Equine Internal Medicine. 3rd ed. St. Louis:
Saunders Elsevier; 2010. p. 757.
14) Textor JA, Tablin F. Activation of equine platelet-rich plasma: comparison of
methods and characterization of equine autologous thrombin. Vet Surg. 2012
Oct;41(7):784–94.
97
15) Textor JA, Norris JW, Tablin F. Effects of preparation method, shear force, and
exposure to collagen on release of growth factors from equine platelet-rich plasma.
Am J Vet Res. 2011 Feb;72(2):271–8.
16) Dhillon RS, Schwarz EM, Maloney MD. Platelet-rich plasma therapy - future or
trend? Arthritis Res Ther. 2012 Aug 8;14(4):219.
17) Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo
KS, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in
flexor digitorum superficialis tendons. J Orthop Res. 2007 Feb;25(2):230–40.
18) Smith JJ, Ross MW, Smith RK. Anabolic effects of acellular bone marrow, platelet
rich plasma, and serum on equine suspensory ligament fibroblasts in vitro. Vet
Comp Orthop Traumatol. 2006;19(1):43–7.
19) Hwang YJ, Choi JY. Addition of mesenchymal stem cells to the scaffold of plateletrich plasma is beneficial for the reduction of the consolidation period in mandibular
distraction osteogenesis. J Oral Maxillofac Surg. 2010 May;68(5):1112–24.
20) Inchingolo F, Tatullo M, Marrelli M, Inchingolo AM, Inchingolo AD, Dipalma G, et
al. Regenerative surgery performed with platelet-rich plasma used in sinus lift
elevation before dental implant surgery: an useful aid in healing and regeneration
of bone tissue. Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1222–6.
98
21) Marukawa E, Oshina H, Iino G, Morita K, Omura K. Reduction of bone resorption
by the application of platelet-rich plasma (PRP) in bone grafting of the alveolar
cleft. J Craniomaxillofac Surg. 2011 Jun;39(4):278–83.
22) Mei-Dan O, Lippi G, Sanchez M, Andia I, Maffulli N. Autologous platelet-rich
plasma: a revolution in soft tissue sports injury management? Phys Sportsmed.
2010 Dec;38(4):127–35.
23) Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of
platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a
double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med.
2011 Jun;39(6):1200–8.
24) Bosch G, van Schie HT, de Groot MW, Cadby JA, van de Lest CH, Barneveld A, et
al. Effect of platelet-rich plasma on the quality of repair of mechanically induced
core lesions in equine superficial digital flexor tendons: A placebo-controlled
experimental study. J Orthop Res. 2010 Feb;28(2):211–7.
25) Waselau M, Sutter WW, Genovese RL, Bertone AL. Intralesional injection of
platelet-rich plasma followed by controlled exercise for treatment of midbody
suspensory ligament desmitis in Standardbred racehorses. J Am Vet Med Assoc.
2008 May 15;232(10):1515–20.
99
26) Brossi PM, Moreira JJ, Machado TS, Baccarin RY. Platelet-rich plasma in
orthopedic therapy: a comparative systematic review of clinical and experimental
data in equine and human musculoskeletal lesions. BMC Vet Res. 2015 Apr
22;11:98.
27) Dahlgren LA. Regenerative medicine therapies for equine wound management. Vet
Clin North Am Equine Pract. 2018 Dec;34(3):605–620.
28) Tambella AM, Martin S, Cantalamessa A, Serri E, Attili AR. Platelet-rich plasma
and other hemocomponents in veterinary regenerative medicine. Wounds. 2018
Nov;30(11):329–336.
29) Sutter WW, Kaneps AJ, Bertone AL. Comparison of hematologic values and
transforming growth factor-β and insulin-like growth factor concentrations in
platelet concentrates obtained by use of buffy coat and apheresis methods from
equine blood. Am J Vet Res. 2004 Jul;65(7):924–30.
30) Yin W, Xu H, Sheng J, Zhu Z, Jin D, Hsu P, et al. Optimization of pure platelet-rich
plasma preparation: A comparative study of pure platelet-rich plasma obtained
using different centrifugal conditions in a single-donor model. Exp Ther Med. 2017
Sep;14(3):2060–2070.
100
31) Vasconcelos E, Figueiredo AC, Seghatchian J. Quality of platelet concentrates
derived by platelet rich plasma, buffy coat and apheresis. Transfus Apher Sci. 2003
Aug;29(1):13–6.
32) Hammond JW, Hinton RY, Curl LA, Muriel JM, Lovering RM. Use of autologous
platelet-rich plasma to treat muscle strain injuries. Am J Sports Med. 2009
Jun;37(6):1135–42.
33) Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich
plasma: A review and author’s perspective. J Cutan Aesthet Surg. 2014 Oct–
Dec;7(4):189–97.
34) Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet
concentrates: from pure platelet-rich plasma (P-PRP) to leukocyte- and platelet-rich
fibrin (L-PRF). Trends Biotechnol. 2009 Mar;27(3):158–67.
35) Magalon J, Chateau AL, Bertrand B, Louis ML, Silvestre A, Giraudo L, et al. DEPA
classification: a proposal for standardizing PRP use and retrospective application of
available devices. BMJ Open Sport Exerc Med. 2016 Feb 4;2(1):e000060.
36) Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine
concentrations are influenced by the cellular composition of platelet-rich plasma.
Am J Sports Med. 2011 Oct;39(10):2135–40.
101
37) Yoshida R, Murray MM. Peripheral blood mononuclear cells enhance the anabolic
effects of platelet-rich plasma on anterior cruciate ligament fibroblasts. J Orthop
Res. 2013 Jan;31(1):29–34.
38) King W, van der Weegen W, Van Drumpt R, Soons H, Toler K, Woodell-May J.
White blood cell concentration correlates with increased concentrartions of IL-1ra
and improvement in WOMAC pain scores in an open-label safety study of
autologous protein solution. J Exp Orthop. 2016 Dec;3(1):9.
39) Boswell SG, Schnabel LV, Mohammed HO, Sundman EA, Minas T, Fortier, LA.
Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma
decrease collagen gene synthesis in tendons. Am J Sports Med. 2014 Jan;42(1):42–
9.
40) Kisiday JD, McIlwraith CW, Rodkey WG, Frisbie DD, Steadman JR. Effects of
platelet-rich plasma composition on anabolic and catabolic activities in equine
cartilage and meniscal explants. Cartilage. 2012 Jul;3(3):245–54.
41) Sano K, Takai Y, Yamanishi J, Nishizuka Y. A role of calcium-activated
phospholipid-dependent protein kinase in human platelet activation. Comparison of
thrombin and collagen actions. J Biol Chem. 1983 Feb 10;258(3):2010–3.
102
42) Sonker A, Dubey A. Determining the effect of preparation and storage: An effort to
streamline platelet components as a source of growth factors for clinical
application. Transfus Med Hemother. 2015 May;42(3):174–80.
43) Zimmermann R, Arnord D, Strasser E, Ringwald J, Schlegel A, Wiltfang J, et al.
Sample preparation technique and white cell content influence the detectable levels
of growth factors in platelet concentrates. Vox Sang. 2003 Nov;85(4):283–9.
44) Hauschild G, Geburek F, Gosheger G, Eveslage M, Serrano D, Streitbürger A, et al,
Mischke R. Short term storage stability at room temperature of two different
platelet-rich plasma preparations from equine donors and potential impact on
growth factor concentrations. BMC Vet Res. 2017 Jan 5;13(1):7.
45) Shin HS, Woo HM, Kang BJ. Optimisation of a double-centrifugation method for
preparation of canine platelet-rich plasma. BMC Vet Res. 2017 Jun 26;13(1):198.
46) Borrione P, Fagnani F, Di Gianfrancesco A, Mancini A, Pigozzi F, Pitsiladis Y. The
role of platelet-rich plasma in muscle healing. Curr Sports Med Rep. 2017
Nov/Dec;16(6):459–463.
47) Giles BM, Underwood TT, Benhadji KA, Nelson DK, Grobeck LM, Lin B, et al.
Analytical characterization of an enzyme-linked immunosorbent assay for the
103
measurement of transforming growth factor β1 in human plasma. J Appl Lab Med.
2018;3:200–212.
48) Karalaki M, Fili S, Philippou A, Koutsilieris M. Muscle regeneration: cellular and
molecular events. In Vivo. 2009 Sep–Oct;23(5):779–96.
49) A Hamid MS, Mohamed Ali MR, Yusof A, George J, Lee LP. Platelet-rich plasma
injections for the treatment of hamstring injuries. Am J Sports Med. 2014
Oct;42(10):2410–8.
50) Kawai M, Aida H, Hiraga A, Miyata H. Muscle satellite cells are activated after
exercise to exhaustion in Thoroughbred horses. Equine Vet J. 2013 Jul;45(4):512–7.
51) Yamano S, Eto D, Kasashima Y, Hiraga A, Sugiura T, Miyata H. Evaluation of
developmental changes in the coexpression of myosin heavy chains and metabolic
properties of equine skeletal muscle fibers. Am J Vet Res. 2005 Mar;66(3):401–5.
52) Shi X, Garry DJ. Muscle stem cells in development, regeneration, and disease.
Genes Dev. 2006 Jul 1;20(13):1692–708.
53) Delos D, Leineweber MJ, Chaudhury S, Alzoobaee S, Gao Y, Rodeo SA. The effect of
platelet-rich plasma on muscle contusion healing in a rat model. Am J Sports Med.
2014 Sep;42(9):2067–74.
104
54) Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE. The phenotype of
murine wound macrophages. J Leukoc Biol. 2010 Jan;87(1):59–67.
55) Zhang C, Li Y, Wu Y, Wang L, Wang X, Du J. Interleukin-6/signal transducer and
activator of transcription 3 (STAT3) pathway is essential for macrophage
infiltration and myoblast proliferation during muscle regeneration. J Biol Chem.
2013 Jan 18;288(3):1489–99.
56) Dimauro I, Grasso L, Fittipaldi S, Fantini C, Mercatelli N, Racca S, et al. Plateletrich plasma and skeletal muscle healing: a molecular analysis of the early phases of
the regeneration process in an experimental animal model. PloS One. 2014 Jul
23;9(7):e102993.
57) Matsuo R, Ohkohchi N, Murata S, Ikeda O, Nakano Y, Watanabe M, et al. Platelets
strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J Surg Res.
2008 Apr;145(2):279–86.
58) Lepper C, Partridge TA, Fan CM. An absolute requirement for Pax7-positive
satellite cells in acute injury-induced skeletal muscle regeneration. Development.
2011 Sep;138(17):3639–46.
105
59) Hamilton B, Tol JL, Almusa E, Boukarroum S, Eirale C, Farooq A, et al. Plateletrich plasma does not enhance return to play in hamstring injuries: a randomised
controlled trial. Br J Sports Med. 2015 Jul;49(14):943–50.
60) Kunze KN, Hannon CP, Fialkoff JD, Frank RM, Cole BJ. Platelet-rich plasma for
muscle injuries: A systematic review of the basic science literature. World J Orthop.
2019 Jul 18;10(7):278–291.
61) Politi PK, Havaki S, Manta P, Lyritis G. Bupivacaine-induced regeneration of rat
soleus muscle: ultrastructural and immunohistochemical aspects. Ultrastruct
Pathol. 2006 Nov-Dec;30(6):461–9.
62) Lagrota-Candido J, Canella I, Pinheiro DF, Santos-Silva LP, Ferreira RS,
Guimarães-Joca FJ, et al. Characteristic pattern of skeletal muscle remodelling in
different mouse strains. Int J Exp Pathol. 2010 Dec;91(6):522–9.
63) Akiyama C, Kobayashi S, Nonaka I. Comparison of behavior in muscle fiber
regeneration after bupivacaine hydrochloride- and acid anhydride-induced
myonecrosis. Acta Neuropathol. 1992;83(6):584–9.
64) Otrocka-Domagała I, Paździor-Czapula K, Gesek M. Dexamethasone-induced
impairment of post-injury skeletal muscle regeneration. BMC Vet Res. 2019 Feb
11;15(1):56.
106
65) Nishino I. ABC in muscle pathology. Rinsho Shinkeigaku. 2011 Sep;51(9):669–76.
[Japanese].
66) Fukuda K, Kuroda T, Tamura N, Mita H, Kasashima Y. Optimal activation methods
for maximizing the concentrations of platelet-derived growth factor-BB and
transforming growth factor-β1 in equine platelet-rich plasma. J Vet Med Sci. 2020
Oct 20;82(10):1472-1479.
67) Tsai WC, Yu TY, Chang GJ, Lin LP, Lin MS, Pang JS. Platelet-rich plasma
releasate promotes regeneration and decreases inflammation and apoptosis of
injured skeletal muscle. Am J Sports Med. 2018 Jul;46(8):1980–1986.
68) Li H, Hicks JJ, Wang L, Oyster N, Philippon MJ, Hurwitz S, et al. Customized
platelet-rich plasma with transforming growth factor β1 neutralization antibody to
reduce fibrosis in skeletal muscle. Biomaterials. 2016 May;87:147–156.
69) Guardiola O, Andolfi G, Tirone M, Iavarone F, Brunelli S, Minchiotti G. Induction
of acute skeletal muscle regeneration by cardiotoxin injection. J Vis Exp. 2017 Jan
1;(119):54515.
70) Bowen-Pope DF, Malpass TW, Foster DM, Ross R. Platelet-derived growth factor in
vivo: levels, activity, and rate of clearance. Blood. 1984 Aug;64(2):458–69.
107
71) Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn
MB. Recombinant latent transforming growth factor beta 1 has a longer plasma
half-life in rats than active transforming growth factor beta 1, and a different
tissue distribution. J Clin Invest. 1990 Dec;86(6):1976–84.
72) Textor JA, Willits NH, Tablin F. Synovial fluid growth factor and cytokine
concentrations after intra-articular injection of a platelet-rich product in horses.
Vet J. 2013 Oct;198(1):217–23.
73) Yamanouchi K, Hosoyama T, Murakami Y, Nakano S, Nishihara M. Satellite cell
differentiation in goat skeletal muscle single fiber culture. J Reprod Dev. 2009
Jun;55(3):252–5.
74) Soeta C, Yamanouchi K, Hasegawa T, Ishida N, Mukoyama H, Tojo H, et al.
Isolation of satellite cells from equine skeletal muscle. J Equine Sci. 1998; 9(3):97–
100.
75) Carter CA, Jolly DG, Worden CE Sr, Hendren DG, Kane CJ. Platelet-rich plasma
gel promotes differentiation and regeneration during equine wound healing. Exp
Mol Pathol. 2003 Jun;74(3):244–55.
108
76) Pereira RCDF, De La Côrte FD, Brass KE, da Silva Azevedo M, Gallio M, Cantarelli
C, et al. Evaluation of three methods of platelet-rich plasma for treatment of equine
distal limb skin wounds. J Equine Vet Sci. 2019 Jan;72:1–7.
77) Kurita J, Miyamoto M, Ishii Y, Aoyama J, Takagi G, Naito Z, et al. Enhanced
vascularization by controlled release of platelet-rich plasma impregnated in
biodegradable gelatin hydrogel. Ann Thorac Surg. 2011 Sep;92(3):837–44;
discussion 844.
78) Carter MJ, Fylling CP, Parnell LK. Use of platelet rich plasma gel on wound
healing: a systematic review and meta-analysis. Eplasty. 2011;11:e38. Epub 2011
Sep 15.
109
...
論文の公開元へ
